Managing Toxicities from Chronic Myeloid Leukemia Treatment

2 Views
administrator
administrator
07/08/23

The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, comment on strategies to manage adverse events from tyrosine kinase inhibitor therapy used in the treatment of chronic myeloid leukemia.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next